Drug Safety

Statins and Monitoring of Liver Function Tests
pp. 1-4(4)
Authors: Kostner, Karam; Howes, Laurence G.

Can We Ensure the Safe Use of Known Human Teratogens?: The iPLEDGE™ Test Case
pp. 5-15(11)
Authors: Honein, Margaret A.; Lindstrom, Jill A.; Kweder, Sandra L.

Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Safety Considerations
pp. 17-26(10)
Authors: Wolraich, Mark L.; McGuinn, Laura; Doffing, Melissa

Drug-Induced Musculoskeletal Disorders
pp. 27-46(20)
Author: Bannwarth, Bernard

Clozapine-Associated Myocarditis: A Review of 116 Cases of Suspected Myocarditis Associated with the Use of Clozapine in Australia During 1993-2003
pp. 47-57(11)
Authors: Haas, Steven J.; Hill, Richard; Krum, Henry; Liew, Danny; Tonkin, Andrew; Demos, Lisa; Stephan, Karen; McNeil, John

A Population-Based Case-Control Teratologic Study of Oral Dipyrone Treatment during Pregnancy
pp. 59-70(12)
Authors: Bánhidy, Ferenc; Ács, Nándor; Puhó, Erzsébet; Czeizel, Andrew E.

Risk Factors Associated with a High Velocity of the Development of Hyperkalaemia in Hospitalised Patients
pp. 71-80(10)
Authors: Indermitte, Jörg; Burkolter, Sabine; Drewe, Jürgen; Krähenbühl, Stephan; Hersberger, Kurt E.

Emergency Department Visits Caused by Adverse Drug Events: Results of a French Survey
pp. 81-88(8)
Authors: Queneau, Patrice; Bannwarth, Bernard; Carpentier, Françoise; Guliana, Jean-Michel; Bouget, Jacques; Trombert, Béatrice; Leverve, Xavier; Lapostolle, Frédéric; Borron, Stephen W.; Adnet, Frédéric

Increase in Nonfatal Digestive Perforations and Haemorrhages following Introduction of Selective NSAIDs: a Public Health Concern
pp. 89-90(2)
Authors: Watson, Douglas J.; Rahme, Elham; Santanello, Nancy C.

The Authors' Reply
pp. 90-91(2)
Authors: Barnard, Louise; Lavoie, Dominic; Lajeunesse, Nancy